China Grand Pharmaceutical and Healthcare Holdings Ltd represents a commitment to providing high-quality healthcare products and services. With a strong emphasis on innovation and research, the company strives to develop effective and safe medicines that contribute to the well-being of individuals. China Grand Pharmaceutical and Healthcare Holdings Ltd also values integrity, transparency, and social responsibility in its business practices. By adhering to these values and corporate philosophy, the company aims to enhance healthcare accessibility and improve the overall quality of life for people in China and beyond.

China Grand Pharmaceutical and Healthcare Holdings Ltd is primarily present in China.

China Grand Pharmaceutical and Healthcare Holdings Ltd, a leading healthcare company, has achieved significant milestones in its journey. Over the years, the company has expanded its presence and made remarkable strides. It has successfully developed and launched various innovative healthcare products, contributing to the improvement of global healthcare standards. China Grand Pharmaceutical and Healthcare Holdings Ltd has received numerous accolades and recognition for its outstanding research and development efforts, quality management, and commitment to patient care. With a strong focus on continuous innovation and growth, the company continues to establish itself as a key player in the pharmaceutical and healthcare industry.

China Grand Pharmaceutical and Healthcare Holdings Ltd is a leading pharmaceutical company in China. Established in 2000, the company has a rich history and extensive experience in the healthcare industry. It specializes in the research, development, manufacturing, and sale of a wide range of pharmaceutical products and healthcare services. With a dedication to innovation and quality, China Grand Pharmaceutical has become a trusted name in the industry. The company focuses on enhancing medical advancements, improving patient well-being, and contributing to the overall development of the pharmaceutical sector in China. China Grand Pharmaceutical continues to grow and expand its portfolio, serving as a driving force in the healthcare industry.

The main competitors of China Grand Pharmaceutical and Healthcare Holdings Ltd in the market include Sinopharm Group Co Ltd, Shanghai Fosun Pharmaceutical Group Co Ltd, and Sino Biopharmaceutical Limited.

China Grand Pharmaceutical and Healthcare Holdings Ltd is primarily active in the pharmaceutical and healthcare industries.

The business model of China Grand Pharmaceutical and Healthcare Holdings Ltd. revolves around its diverse healthcare portfolio. As a leading pharmaceutical company based in China, it engages in the research, development, production, and distribution of a wide range of pharmaceutical products and medical devices. The company's core focus lies in the fields of innovative drug discovery, modernized traditional Chinese medicine, and the provision of high-quality medical services. With a dedication to improving healthcare outcomes, China Grand Pharmaceutical and Healthcare Holdings Ltd. aims to meet the evolving needs of patients and healthcare professionals, while contributing to the advancement of the healthcare industry.

مُعامل القيمة السوقية إلى الأرباح لـ Grand Pharmaceutical Group هو ٧٫٤٣.

مُعامِل القيمة إلى المبيعات Grand Pharmaceutical Group هو ١٫٣٧.

نقاط جودة AlleAktien لـ Grand Pharmaceutical Group هي 9/10.

المتوقعة Grand Pharmaceutical Group الإيرادات هي ١٢٫٠٧ مليارات HKD.

صافي الربح المتوقعة Grand Pharmaceutical Group هو ٢٫٢٣ مليارات HKD.

China Grand Pharmaceutical and Healthcare Holdings Ltd is a leading company in the Chinese biotechnology and pharmaceutical industry. It offers a variety of products and services, including medications, health products, and medical devices. The core business areas of China Grand include research and development, production and marketing of medications, health products, and medical devices, as well as operating clinics and hospitals. China Grand's research and development department focuses on discovering, developing, and marketing innovative medications for diseases such as cancer, diabetes, cardiovascular diseases, and infectious diseases. The company has become a major player in the Chinese biotechnology industry through extensive investments and strategic partnerships. In addition to developing its own medications, China Grand has also acquired licenses for marketing foreign medications. The company provides its customers with a wide range of medications that meet the highest quality and safety standards. China Grand's health product division offers a wide range of products aimed at promoting the health and well-being of customers. These include dietary supplements, vitamins, herbal extracts, traditional Chinese medicine products, and cosmetic products. These products are sold both online and through a broad distribution channel in pharmacies and drugstores. China Grand's medical devices division produces a wide range of devices and instruments used by clinics, hospitals, and other medical facilities for diagnosing and treating diseases. These include ultrasound devices, X-ray machines, CT scanners, magnetic resonance imaging machines, and other medical devices. In addition to its product lines, China Grand also operates a number of its own clinics and hospitals that offer a wide range of medical services. China Grand's clinics are known for their modern facilities, state-of-the-art medical equipment, and excellent staff. Overall, China Grand Pharmaceutical and Healthcare Holdings Ltd offers a wide range of products and services that meet the needs of customers throughout the Chinese healthcare industry. The company is well positioned to benefit from the strong growth in the Chinese healthcare industry and further expand its leading role in the industry.

يوزع Grand Pharmaceutical Group أرباحًا قدرها ٠٫١١ HKD من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Grand Pharmaceutical Group في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـGrand Pharmaceutical Group هو BMG210A71016.

رمز WKN لـ Grand Pharmaceutical Group هو A0Q8LD.

الرمز المُختصر لـ Grand Pharmaceutical Group هو 512.HK.

خلال آخر 12 شهراً، دفعت Grand Pharmaceutical Group توزيعات أرباح بقيمة ٠٫١٤ HKD . وهذا يعادل عائد توزيعات أرباح يقارب ٢٫٩٧ %. ومن المتوقع أن تدفع Grand Pharmaceutical Group خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫١٦ HKD.

نسبة توزيعات الأرباح الحالية لـ Grand Pharmaceutical Group هي ٢٫٩٧ %.

Grand Pharmaceutical Group يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يوليو, يوليو, يوليو, يوليو.

Grand Pharmaceutical Group دفعت توزيعات الأرباح كل عام خلال الـ8 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫١٦ HKD. وهذا يعادل عائد توزيعات أرباح قدره ٣٫٣٢ %.

Grand Pharmaceutical Group يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٢٦ HKD من Grand Pharmaceutical Group المُعلن عنها في ٢٧‏/٦‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٦‏/٦‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٢٧‏/٦‏/٢٠٢٤.

في العام 2023، وزعت Grand Pharmaceutical Group ٠٫١١ HKD كأرباح أسهم.

يتم توزيع أرباح Grand Pharmaceutical Group بالعملة HKD.